Literature DB >> 17002586

Enhanced osteoclastogenesis in 4-1BB-deficient mice caused by reduced interleukin-10.

Hyun-Hee Shin1, Ji-Eun Lee, Eun A Lee, Byoung Se Kwon, Hye-Seon Choi.   

Abstract

UNLABELLED: Enhanced osteoclastogenesis was observed in bone marrow-derived macrophage cells from 4-1BB-deficient mice than in those from wildtype mice. 4-1BB and 4-1BB ligand interaction may play a role at a certain stage of osteoclast formation through increased level of IL-10, a negative regulator of osteoclastogenesis.
INTRODUCTION: 4-1BB is an inducible T-cell costimulatory molecule and a member of the TNF receptor family. The expression pattern of 4-1BB and 4-1BB ligand (4-1BBL) has suggested that 4-1BB plays a role not only in various responses related to innate immunity but also in bone metabolism.
MATERIALS AND METHODS: Osteoclast formation was evaluated in bone marrow-derived macrophage cells (BMMs) from wildtype and 4-1BB-deficient (4-1BB-/-) mice. Expression of interleukin-10 (IL-10) during osteoclast formation was analyzed at the mRNA and protein levels.
RESULTS: Expression of IL-10 was higher in RANKL-stimulated wildtype BMMs than 4-1BB-/- BMMs. When 4-1BBL was stimulated with 4-1BB-Fc fusion protein, the expression of IL-10 in BMMs increased. Neutralization of IL-10 was not as effective in preventing inhibition by IL-10 of osteoclast differentiation in 4-1BB-/- BMMs as in wildtype BMMs. When IL-10 was added to the culture medium, osteoclast formation was inhibited more efficiently in the 4-1BB-/- BMMs than in the wildtype BMMs.
CONCLUSIONS: Interaction of 4-1BB and 4-1BBL stimulates IL-10 production through 4-1BBL signaling. 4-1BBL plays a role at a certain stage of osteoclast formation, and IL-10 may mediate this effect. The elevated level of osteoclastogenesis in 4-1BB-/- BMMs may thus be caused, in part, by a lower level of IL-10.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002586     DOI: 10.1359/jbmr.060813

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

2.  Saturated fatty acids enhance osteoclast survival.

Authors:  So-Ra Oh; Ok-Joo Sul; Youn-Young Kim; Hye-Jin Kim; Rina Yu; Jae-Hee Suh; Hye-Seon Choi
Journal:  J Lipid Res       Date:  2010-05       Impact factor: 5.922

3.  4-1BB ligand signaling to T cells limits T cell activation.

Authors:  So-Young Eun; Seung-Woo Lee; Yanfei Xu; Michael Croft
Journal:  J Immunol       Date:  2014-11-17       Impact factor: 5.422

Review 4.  Reverse signaling through the co-stimulatory ligand, CD137L, as a critical mediator of sterile inflammation.

Authors:  Sang Jun Park; Hye Jeong Kim; Jong Soo Lee; Hong Rae Cho; Byungsuk Kwon
Journal:  Mol Cells       Date:  2012-04-20       Impact factor: 5.034

5.  IL-27 Modulates the Cytokine Secretion in the T Cell-Osteoclast Crosstalk During HIV Infection.

Authors:  Tong Li; Colleen Hadigan; Jarred M Whitlock; Jing Qin; Jai Kumar; Princy Kumar; Marta Catalfamo
Journal:  Front Immunol       Date:  2022-04-05       Impact factor: 8.786

6.  TLR2 deletion promotes arthritis through reduction of IL-10.

Authors:  Qi-Quan Huang; Renee E Koessler; Robert Birkett; Harris Perlman; Lianping Xing; Richard M Pope
Journal:  J Leukoc Biol       Date:  2013-02-27       Impact factor: 4.962

Review 7.  Osteoimmunology: cytokines and the skeletal system.

Authors:  Seoung-Hoon Lee; Tae-Soo Kim; Yongwon Choi; Joseph Lorenzo
Journal:  BMB Rep       Date:  2008-07-31       Impact factor: 4.778

8.  Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus.

Authors:  Kathryn E Evans; Simon W Fox
Journal:  BMC Cell Biol       Date:  2007-01-19       Impact factor: 4.241

Review 9.  4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity.

Authors:  Todd Bartkowiak; Michael A Curran
Journal:  Front Oncol       Date:  2015-06-08       Impact factor: 6.244

Review 10.  Interleukin-10 inhibits bone resorption: a potential therapeutic strategy in periodontitis and other bone loss diseases.

Authors:  Qian Zhang; Bin Chen; Fuhua Yan; Jianbin Guo; Xiaofeng Zhu; Shouzhi Ma; Wenrong Yang
Journal:  Biomed Res Int       Date:  2014-02-16       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.